cromakalim has been researched along with 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryan, PT; Marshall, JM | 1 |
| Beech, DJ; Prior, HM; Yates, MS | 1 |
| Davie, CS; Everitt, DE; Standen, NB | 1 |
| Al-Ayadhi, LY; Al-Tuwajri, AS | 1 |
| Jamal Mustafa, S; Ledent, C; Nayeem, MA; Ponnoth, DS; Tilley, SL | 1 |
5 other study(ies) available for cromakalim and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine
| Article | Year |
|---|---|
Cellular mechanisms by which adenosine induces vasodilatation in rat skeletal muscle: significance for systemic hypoxia.
Topics: Adenosine; Animals; Antihypertensive Agents; Blood Pressure; Cromakalim; Enzyme Inhibitors; Femoral Artery; Glyburide; Heart Rate; Hypoglycemic Agents; Hypoxia; Male; Muscle, Skeletal; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitroprusside; Phenethylamines; Potassium Channel Blockers; Potassium Channels; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Regional Blood Flow; Vasodilator Agents | 1999 |
Role of K+ channels in A2A adenosine receptor-mediated dilation of the pressurized renal arcuate artery.
Topics: 4-Aminopyridine; Adenosine; Amifampridine; Animals; Antihypertensive Agents; Apamin; Arteries; Barium; Cromakalim; Enzyme Inhibitors; Glyburide; In Vitro Techniques; Kidney; Male; Nicardipine; Ouabain; Peptides; Phenethylamines; Potassium; Potassium Channels; Pressure; Purinergic P1 Receptor Agonists; Rabbits; Receptor, Adenosine A2A; Receptors, Purinergic P1; Vasodilation; Vasodilator Agents | 1999 |
Increase in the vasorelaxant potency of K(ATP) channel opening drugs by adenosine A(1) and A(2) receptors in the pig coronary artery.
Topics: Adenosine; Animals; ATP-Binding Cassette Transporters; Coronary Vessels; Cromakalim; Dose-Response Relationship, Drug; Drug Interactions; In Vitro Techniques; KATP Channels; Nicorandil; Phenethylamines; Pinacidil; Potassium Channels; Potassium Channels, Inwardly Rectifying; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Swine; Triazines; Triazoles; Vasodilator Agents; Xanthines | 1999 |
The synergistic effect of adenosine A2A receptors agonist, type IV phosphodiestease inhibitor and ATP-sensitive K channels activation on free radicals production and aggregation of human polymorphoneuclear leukocytes.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine A2 Receptor Agonists; Cell Aggregation; Cell Survival; Cromakalim; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Synergism; Free Radicals; Humans; Luminescent Measurements; Luminol; Neutrophils; Phenethylamines; Phosphodiesterase Inhibitors; Potassium Channels, Inwardly Rectifying; Reactive Oxygen Species; Receptor, Adenosine A2A; Respiratory Burst; Rolipram; Tetradecanoylphorbol Acetate | 2004 |
CYP-epoxygenases contribute to A2A receptor-mediated aortic relaxation via sarcolemmal KATP channels.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Alcohol Oxidoreductases; Animals; Cromakalim; Decanoic Acids; Female; Glyburide; Hydroxy Acids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidoreductases; Phenethylamines; Pinacidil; Receptor, Adenosine A2A; Sarcolemma | 2012 |